| Literature DB >> 28977943 |
Qing-Wei Zhang1, Xiao-Lu Lin1,2, Chi-Hao Zhang3, Chen-Yue Tang4, Xin-Tian Zhang1, La-Mei Teng1,5, Zhi-Zheng Ge1, Xiao-Bo Li1.
Abstract
BACKGROUND AND AIMS: Multiple studies have shown that marital status is associated with the survival of various types of cancer patients. However, there has not been adequate evidence of the association between marital status and the survival of patients with esophageal cancer (EC). We aimed to investigate the effect of marital status on survival of EC patients.Entities:
Keywords: CSS; OS; SEER; esophageal cancer; marital status
Year: 2017 PMID: 28977943 PMCID: PMC5617503 DOI: 10.18632/oncotarget.19446
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Characteristics of patients with esophageal carcinomas in SEER database
| Characteristics | Total | Married | Unmarried | Divorced | Single | Widowed |
|---|---|---|---|---|---|---|
| 15598 (100%) | 9279 (59.49%) | 6319 (40.51%) | 1971 (12.64%) | 2592 (16.62%) | 1756 (11.26%) | |
| Male | 12581 (80.66%) | 8093 (87.22%) | 4488 (71.02%) | 1555 (78.89%) | 2083 (80.36%) | 850 (48.41%) |
| Female | 3017 (19.34%) | 1186 (12.78%) | 1831 (28.98%) | 416 (21.11%) | 509 (19.64%) | 906 (51.59%) |
| White | 13241 (84.89%) | 8297 (89.42%) | 4944 (78.24%) | 1629 (82.65%) | 1879 (72.49%) | 1436 (81.78%) |
| Black | 1583 (10.15%) | 480 (5.17%) | 1103 (17.46%) | 273 (13.85%) | 609 (23.50%) | 221 (12.59%) |
| Other race | 774 (4.96%) | 502 (5.41%) | 272 (4.30%) | 69 (3.50%) | 104 (4.01%) | 99 (5.64%) |
| <40 | 216 (1.38%) | 103 (1.11%) | 113 (1.79%) | 16 (0.81%) | 95 (3.67%) | 2 (0.11%) |
| 41-55 | 2985 (19.14%) | 1604 (17.29%) | 1381 (21.85%) | 466 (23.64%) | 863 (33.29%) | 52 (2.96%) |
| 56-70 | 7233 (46.37%) | 4565 (49.20%) | 2668 (42.22%) | 1062 (53.88%) | 1175 (45.33%) | 431 (24.54%) |
| 71-85 | 4416 (28.31%) | 2687 (28.96%) | 1729 (27.36%) | 399 (20.24%) | 396 (15.28%) | 934 (53.19%) |
| >85 | 748 (4.80%) | 320 (3.45%) | 428 (6.77%) | 28 (1.42%) | 63 (2.43%) | 337 (19.19%) |
| ESCC | 4725 (30.29%) | 2231 (24.04%) | 2494 (39.47%) | 696 (35.31%) | 1071 (41.32%) | 727 (41.40%) |
| EAC | 9530 (61.10%) | 6193 (66.74%) | 3337 (52.81%) | 1119 (56.77%) | 1348 (52.00%) | 870 (49.54%) |
| Others | 1343 (8.61%) | 855 (9.21%) | 488 (7.72%) | 156 (7.91%) | 173 (6.67%) | 159 (9.05%) |
| Well differentiated | 844 (5.41%) | 507 (5.46%) | 337 (5.33%) | 100 (5.07%) | 136 (5.25%) | 101 (5.75%) |
| Moderately differentiated | 6276 (40.24%) | 3592 (38.71%) | 2684 (42.48%) | 834 (42.31%) | 1120 (43.21%) | 730 (41.57%) |
| Poorly differentiated | 8172 (52.39%) | 5002 (53.91%) | 3170 (50.17%) | 1009 (51.19%) | 1290 (49.77%) | 871 (49.60%) |
| Undifferentiated | 306 (1.96%) | 178 (1.92%) | 128 (2.03%) | 28 (1.42%) | 46 (1.77%) | 54 (30.75%) |
| Upper third of esophagus | 1053 (6.75%) | 481 (5.18%) | 572 (9.05%) | 167 (8.47%) | 245 (9.45%) | 160 (9.11%) |
| Middle third of esophagus | 3186 (20.43%) | 1595 (17.19%) | 1591 (25.18%) | 459 (23.29%) | 655 (25.27%) | 477 (27.16%) |
| Lower third of esophagus | 11359 (72.82%) | 7203 (77.63%) | 4156 (65.77%) | 1345 (68.24%) | 1692 (65.28%) | 1119 (63.72%) |
| Stage I | 2548 (16.34%) | 1495 (16.11%) | 1053 (16.67%) | 266 (13.50%) | 385 (14.85%) | 402 (22.89%) |
| Stage II | 3317 (21.27%) | 1949 (21.00%) | 1368 (21.65%) | 428 (21.71%) | 524 (20.22%) | 416 (23.69%) |
| Stage III | 3733 (23.93%) | 2299 (24.78%) | 1434 (22.69%) | 487 (24.71%) | 595 (22.96%) | 352 (20.04%) |
| Stage IV | 6000 (38.47%) | 3536 (38.11%) | 2464 (38.99%) | 790 (40.08%) | 1088 (41.98%) | 586 (33.37%) |
| No surgery or radiotherapy | 10247 (65.69%) | 5608 (60.44%) | 4639 (73.41%) | 1371 (69.56%) | 1854 (71.53%) | 1414 (80.52%) |
| Only surgery | 2107 (13.51%) | 1393 (15.01%) | 714 (11.30%) | 224 (11.36%) | 319 (12.31%) | 171 (9.74%) |
| Only radiotherapy | 359 (2.30%) | 224 (2.41%) | 135 (2.14%) | 45 (2.28%) | 62 (2.39%) | 28 (1.59%) |
| Surgery and radiotherapy | 2885 (18.50%) | 2054 (22.14%) | 831 (13.15%) | 331 (16.79%) | 357 (13.77%) | 143 (8.14%) |
SEER=surveillance, epidemiology and end results; ESCC=esophageal squamous cell carcinoma; EAC=esophageal adenocarcinoma; TNM= tumor, node and metastasis.
Figure 1Kaplan–Meier survival plots of the 15,558 patients with esophageal cancers according to marital status (A) overall survival; (B) esophageal cancer cause-specific survival.
Univariate and multivariate Cox regression analysis for evaluating the influence of marital status on OS and esophageal cancer CSS in 15598 unmatched cohort with esophageal cancer in SEER database
| Variable | OS | CSS | ||||||
|---|---|---|---|---|---|---|---|---|
| Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |||||
| HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | |
| Married | Reference | Reference | Reference | Reference | ||||
| Unmarried | 1.28 (1.24-1.33) | <0.001 | 1.22 (1.18-1.27) | <0.001 | 1.26 (1.21-1.31) | <0.001 | 1.21 (1.16-1.26) | <0.001 |
| Male | Reference | Reference | Reference | Reference | ||||
| Female | 0.99 (0.95-1.04) | 0.854 | 0.86 (0.82-0.90) | <0.001 | 1.00 (0.95-1.05) | 0.950 | 0.88 (0.84-0.93) | <0.001 |
| White | Reference | Reference | Reference | Reference | ||||
| Black | 1.32 (1.24-1.40) | <0.001 | 1.16 (1.09-1.24) | <0.001 | 1.30 (1.22-1.38) | <0.001 | 1.15 (1.07-1.23) | <0.001 |
| Other race | 1.01 (0.93-1.10) | 0.763 | 0.94 (0.86-1.02) | 0.154 | 1.01 (0.92-1.11) | 0.823 | 0.94 (0.86-1.03) | 0.218 |
| (<40) vs (41-55) vs (56-70) vs (71-85) vs (>85) | 1.21 (1.18-1.24) | <0.001 | 1.19 (1.16-1.22) | <0.001 | 1.16 (1.14-1.19) | <0.001 | 1.16 (1.14-1.19) | <0.001 |
| ESCC | Reference | Reference | Reference | Reference | ||||
| EAC | 0.84 (0.81-0.88) | <0.001 | 0.99 (0.93-1.05) | 0.649 | 0.86 (0.82-0.9) | <0.001 | 0.86 (0.82-0.9) | <0.001 |
| Others | 1.14 (1.06-1.22) | <0.001 | 1.14 (1.05-1.24) | 0.001 | 1.17 (1.10-1.27) | <0.001 | 1.17 (1.10-1.27) | <0.001 |
| I vs II vs III vs IV | 1.30 (1.27-1.34) | <0.001 | 1.17 (1.14-1.21) | <0.001 | 1.36 (1.31-1.40) | <0.001 | 1.21 (1.17-1.25) | <0.001 |
| Upper third of esophagus | Reference | Reference | Reference | Reference | ||||
| Middle third of esophagus | 1.03 (0.95-1.11) | 0.517 | 1.15 (1.07-1.25) | <0.001 | 1.03 (0.95-1.13) | 0.373 | 1.17 (1.07-1.27) | 0.001 |
| Lower third of esophagus | 0.90 (0.84-0.97) | 0.007 | 1.13 (1.04-1.23) | 0.003 | 0.93 (0.86-1.01) | 0.080 | 1.14 (1.04-1.24) | 0.004 |
| I vs II vs III vs IV | 1.55 (1.52-1.58) | <0.001 | 1.38 (1.36-1.41) | <0.001 | 1.65 (1.62-1.69) | <0.001 | 1.46 (1.43-1.49) | <0.001 |
| Surgery and radiotherapy | Reference | Reference | Reference | Reference | ||||
| Only surgery | 0.80 (0.74-0.86) | <0.001 | 1.01 (0.94-1.03) | 0.445 | 0.74 (0.68-0.81) | <0.001 | 0.99 (0.91-1.08) | 0.817 |
| Only radiotherapy | 2.08 (1.84-2.35) | <0.001 | 1.63 (1.44-1.85) | <0.001 | 2.22 (1.95-2.53) | <0.001 | 1.68 (1.48-1.92) | <0.001 |
| No surgery or radiotherapy | 2.94 (2.79-3.09) | <0.001 | 2.44 (2.31-2.57) | <0.001 | 3.04 (2.87-3.21) | <0.001 | 2.49 (2.35-2.64) | <0.001 |
SEER=surveillance, epidemiology and end results; OS=overall survival; CSS=cause-specific survival; ESCC=esophageal squamous cell carcinoma; EAC=esophageal adenocarcinoma; TNM= tumor, node and metastasis.
Figure 2Kaplan–Meier survival plots of the 15,558 patients with esophageal cancers among single, married, widowed, and divorced patients (A) overall survival; (B) esophageal cancer cause-specific survival.
Univariate and multivariate Cox regression analysis of unmarried status compared with married status on OS and esophageal cancer CSS based on different 6th AJCC stage in 15598 unmatched cohort with esophageal cancer
| Variable | OS | CSS | ||||||
|---|---|---|---|---|---|---|---|---|
| Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |||||
| HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | |
| Married | Reference | Reference | Reference | Reference | ||||
| Unmarried | 1.59 (1.44-1.76) | <0.001 | 1.27 (1.14-1.42) | <0.001 | 1.70 (1.52-1.92) | <0.001 | 1.30 (1.15-1.47) | <0.001 |
| Married | Reference | Reference | Reference | Reference | ||||
| Unmarried | 1.27 (1.17-1.38) | <0.001 | 1.19 (1.09-1.30) | <0.001 | 1.25 (1.14-1.37) | <0.001 | 1.17 (1.06-1.29) | 0.002 |
| Married | Reference | Reference | Reference | Reference | ||||
| Unmarried | 1.36 (1.26-1.46) | <0.001 | 1.28 (1.18-1.38) | <0.001 | 1.33 (1.22-1.43) | <0.001 | 1.25 (1.15-1.36) | <0.001 |
| Married | Reference | Reference | Reference | Reference | ||||
| Unmarried | 1.22 (1.15-1.29) | <0.001 | 1.20 (1.13-1.27) | <0.001 | 1.20 (1.13-1.27) | <0.001 | 1.18 (1.11-1.25) | <0.001 |
AJCC= American Joint Committee on Cancer; OS=overall survival; CSS=cause-specific survival; TNM= tumor, node and metastasis.
Univariate and multivariate Cox regression analysis of divorced, single and widowed status compared with married status on OS and esophageal cancer CSS based on different 6thAJCC stage in 15598 unmatched cohort with esophageal cancer
| Variable | OS | CSS | ||||||
|---|---|---|---|---|---|---|---|---|
| Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |||||
| HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | |
| Married | Reference | Reference | Reference | Reference | ||||
| Divorced | 1.41 (1.19-1.66) | <0.001 | 1.37 (1.16-1.63) | <0.001 | 1.47 (1.22-1.78) | <0.001 | 1.37 (1.13-1.67) | <0.001 |
| Single | 1.21 (1.05-1.41) | 0.011 | 1.14 (0.98-1.32) | 0.100 | 1.24 (1.05-1.48) | 0.013 | 1.11 (0.93-1.32) | 0.257 |
| Widowed | 2.29 (2.01-2.62) | <0.001 | 1.36 (1.17-1.57) | <0.001 | 2.55 (2.20-2.96) | <0.001 | 1.45 (1.23-1.71) | <0.001 |
| Married | Reference | Reference | Reference | Reference | ||||
| Divorced | 1.19 (1.05-1.35) | 0.007 | 1.18 (1.04-1.34) | 0.013 | 1.19 (1.04-1.37) | 0.011 | 1.17 (1.02-1.35) | 0.025 |
| Single | 1.15 (1.02-1.29) | 0.023 | 1.17 (1.03-1.33) | 0.012 | 1.11 (0.97-1.26) | 0.135 | 1.11 (0.97-1.27) | 0.130 |
| Widowed | 1.53 (1.36-1.73) | <0.001 | 1.21 (1.06-1.39) | 0.005 | 1.53 (1.34-1.74) | <0.001 | 1.24 (1.07-1.43) | 0.005 |
| Married | Reference | Reference | Reference | Reference | ||||
| Divorced | 1.29 (1.16-1.44) | <0.001 | 1.29 (1.15-1.44) | <0.001 | 1.25 (1.11-1.40) | <0.001 | 1.24 (1.10-1.40) | <0.001 |
| Single | 1.26 (1.14-1.40) | <0.001 | 1.25 (1.12-1.39) | <0.001 | 1.26 (1.13-1.40) | <0.001 | 1.24 (1.11-1.39) | <0.001 |
| Widowed | 1.69 (1.49-1.91) | <0.001 | 1.31 (1.14-1.49) | <0.001 | 1.62 (1.41-1.85) | <0.001 | 1.27 (1.10-1.46) | 0.001 |
| Married | Reference | Reference | Reference | Reference | ||||
| Divorced | 1.16 (1.07-1.26) | <0.001 | 1.16 (1.07-1.27) | <0.001 | 1.13 (1.04-1.23) | 0.005 | 1.13 (1.04-1.24) | 0.006 |
| Single | 1.21 (1.12-1.30) | <0.001 | 1.23 (1.14-1.33) | <0.001 | 1.20 (1.11-1.30) | <0.001 | 1.23 (1.13-1.33) | <0.001 |
| Widowed | 1.32 (1.20-1.46) | <0.001 | 1.17 (1.06-1.30) | 0.003 | 1.30 (1.18-1.44) | <0.001 | 1.15 (1.03-1.28) | 0.011 |
AJCC= American Joint Committee on Cancer; OS=overall survival; CSS=cause-specific survival; TNM= tumor, node and metastasis.
Figure 3Kaplan–Meier survival plots in patients with esophageal cancers in the matched cohort with 2,986 unmarried and 2,986 married patients according to marital status (A) overall survival; (B) esophageal cancer cause-specific survival.
Figure 4Forest plot presenting the contribution of unmarried status compared with that of married status to the survival rates of patients in the subgroups of the matched cohort according to different clinicopathological factors (A) overall survival; (B) esophageal cancer cause-specific survival. HR > 1 with P < 0.05 meant that unmarried status contributed significantly to poorer survival than married status.